GIRIJAVALLABHAN, VINAY,NJOROGE, F. GEORGE,BOGEN, STEPHANE,KEREKES, ANGELA,BENNETT, FRANK,HUANG, YING,NAIR, LATHA,PISSARNITZKI, DIMITRI,VERMA, VISHAL,DANG, QUN,DAVIES, IAN,OLSEN, DAVID, B.,STAMFORD, AN
申请号：
EP12770821
公开号：
EP2696679A4
申请日:
2012.04.11
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to 2&prime；-Cyano Substituted Nucleoside Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein B, X, R1, R2 and R3 are as defined herein. The present invention also relates to compositions comprising at least one 2&prime；-Cyano Substituted Nucleoside Derivative, and methods of using the 2&prime；-Cyano Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.
